119 related articles for article (PubMed ID: 6132056)
1. Is ketanserin a D receptor antagonist?
Lancet; 1983 Mar; 1(8326 Pt 1):703-4. PubMed ID: 6132056
[No Abstract] [Full Text] [Related]
2. Mechanism of the hypotensive effect of ketanserin.
Fozard JR
J Cardiovasc Pharmacol; 1982; 4(5):829-38. PubMed ID: 6182416
[No Abstract] [Full Text] [Related]
3. Characterization of the antihypertensive properties of ketanserin (R 41 468) in rats.
Kalkman HO; Timmermans PB; Van Zwieten PA
J Pharmacol Exp Ther; 1982 Jul; 222(1):227-31. PubMed ID: 6283070
[No Abstract] [Full Text] [Related]
4. Mechanism of antihypertensive action of ketanserin in man.
Reimann IW; Frölich JC
Br Med J (Clin Res Ed); 1983 Aug; 287(6389):381-3. PubMed ID: 6135489
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients.
Amery A; Fagard R; Fiocchi R; Lijnen P; Staessen J; Vermylen J
J Cardiovasc Pharmacol; 1984; 6(1):182-5. PubMed ID: 6199602
[TBL] [Abstract][Full Text] [Related]
6. Control of preeclamptic hypertension by ketanserin, a new serotonin receptor antagonist.
Weiner CP; Socol ML; Vaisrub N
Am J Obstet Gynecol; 1984 Jul; 149(5):496-500. PubMed ID: 6377898
[TBL] [Abstract][Full Text] [Related]
7. Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonist.
Andrén L; Svensson A; Dahlöf B; Eggertsen R; Hansson L
Acta Med Scand; 1983; 214(2):125-30. PubMed ID: 6353879
[TBL] [Abstract][Full Text] [Related]
8. Lack of a difference between ketanserin and ritanserin in central vs. peripheral serotonin receptor antagonism.
Cohen ML; Bloomquist WL; Snoddy HD; Fuller RW
Life Sci; 1989; 45(13):1185-9. PubMed ID: 2507847
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive properties of ketanserin (R 41 468).
Vanhoutte PM; Van Nueten JM; Symoens J; Janssen PA
Fed Proc; 1983 Feb; 42(2):182-5. PubMed ID: 6295821
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive effects of chronic 5-hydroxytryptamine (5-HT2) receptor blockade with ketanserin in the spontaneously hypertensive rat.
Pettersson A; Persson B; Henning M; Hedner T
Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):43-7. PubMed ID: 6493349
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of ketanserin.
Millar JA; Facoory BD; Laverty R
Lancet; 1982 Nov; 2(8308):1154. PubMed ID: 6128465
[No Abstract] [Full Text] [Related]
12. Three distinct subtypes of serotonergic receptors mediate the triphasic blood pressure response to serotonin in rats.
Kalkman HO; Engel G; Hoyer D
J Hypertens Suppl; 1984 Dec; 2(3):S143-5. PubMed ID: 6599662
[TBL] [Abstract][Full Text] [Related]
13. Can peripheral serotonergic blockade explain the hypotensive effect of ketanserin?
Vanhoutte PM
J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S105-9. PubMed ID: 2412025
[TBL] [Abstract][Full Text] [Related]
14. On the mechanism of action of ketanserin, a selective antagonist of the S2 receptors with antihypertensive activity.
Rión R; Mena MA; Hong E
Proc West Pharmacol Soc; 1983; 26():373-5. PubMed ID: 6889366
[No Abstract] [Full Text] [Related]
15. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
Cohen ML; Schenck KW; Kurz KD
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of ketanserin and metoprolol in essential hypertension.
Seedat YK; Parag KB
S Afr Med J; 1985 Oct; 68(8):555-8. PubMed ID: 2931840
[TBL] [Abstract][Full Text] [Related]
17. Acute blood-pressure-lowering effect of ketanserin.
De Cree J; Verhaegen H; Symoens J
Lancet; 1981 May; 1(8230):1161-2. PubMed ID: 6112515
[No Abstract] [Full Text] [Related]
18. Ketanserin: haemodynamic effects and mechanism of action.
Schalekamp MA; Woittiez AJ; Wenting GJ; van den Meiracker AH; Man in 't Veld AJ
J Hypertens Suppl; 1986 Apr; 4(1):S7-12. PubMed ID: 2871144
[TBL] [Abstract][Full Text] [Related]
19. Studies on the mechanism of action of the hypotensive effect of ketanserin.
Marwood JF; Stokes GS
Clin Exp Pharmacol Physiol; 1984; 11(2):125-32. PubMed ID: 6086191
[TBL] [Abstract][Full Text] [Related]
20. Ketanserin and malignant hyperthermia in pigs.
Ording H; Hald A; Sjøntoft E
Acta Anaesthesiol Scand; 1986 Jan; 30(1):7-9. PubMed ID: 2938396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
